ConductScience.org, home

Paper35669482

Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis.

Chen X and 11 others. Front Cardiovasc Med, 2022. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis. Papers, record 35669482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35669482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis.
PubMed
Journal
Front Cardiovasc Med
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2022-07-16
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen XXue
2Jiang AAimin
3Zhang RRui
4Fu XXiao
5Liu NNa
6Shi CChuchu
7Wang JJingjing
8Zheng XXiaoqiang
9Tian TTao
10Liang XXuan
11Ruan ZZhiping
12Yao YYu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131988143Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.J Immunother Cancer2020https://conductscience.org/library/papers/31988143PubMed
225705383Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome.J Immunother Cancer2015https://conductscience.org/library/papers/25705383PubMed
330453170Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors.Eur J Cancer2019https://conductscience.org/library/papers/30453170PubMed
425901283Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.J Immunother Cancer2015https://conductscience.org/library/papers/25901283PubMed
529802219Immune Checkpoint Inhibitor-Associated Myocarditis.Oncologist2018https://conductscience.org/library/papers/29802219PubMed
627806233Fulminant Myocarditis with Combination Immune Checkpoint Blockade.N Engl J Med2016https://conductscience.org/library/papers/27806233PubMed
730993259Managing cardiotoxicity associated with immune checkpoint inhibitors.Chronic Dis Transl Med2019https://conductscience.org/library/papers/30993259PubMed
830242316Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.JAMA Oncol2018https://conductscience.org/library/papers/30242316PubMed
930589930Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.JAMA Oncol2019https://conductscience.org/library/papers/30589930PubMed
1029158217Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.Circulation2017https://conductscience.org/library/papers/29158217PubMed
1111298087T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective.Clin Endocrinol (Oxf)2001https://conductscience.org/library/papers/11298087PubMed
1231169866Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.JAMA Oncol2019https://conductscience.org/library/papers/31169866PubMed
1329209563Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.Oncoimmunology2017https://conductscience.org/library/papers/29209563PubMed
1431390169Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-OncologyCirculation2019https://conductscience.org/library/papers/31390169PubMed
1529536852Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis.Lancet2018https://conductscience.org/library/papers/29536852PubMed
1629567210Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.J Am Coll Cardiol2018https://conductscience.org/library/papers/29567210PubMed
1734030688Effects of diabetes on the development of radiation pneumonitis.Respir Res2021https://conductscience.org/library/papers/34030688PubMed
1829379889A unique reason for coronary spasm causing temporary ST elevation myocardial infarction (inferior STEMI) - systemic inflammatory response syndrome after use of pembrolizumab.Arch Med Sci Atheroscler Dis2017https://conductscience.org/library/papers/29379889PubMed
1934607896Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach.J Immunother Cancer2021https://conductscience.org/library/papers/34607896PubMed
2033714688Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines.Trends Immunol2021https://conductscience.org/library/papers/33714688PubMed

See all 24 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
41859044Preliminary exploration of the role of CD8+ T cells in anti-PD-1 antibody-induced myocarditis in C57BL/6 mice with Lewis lung carcinoma.Biomed Rep2026https://conductscience.org/library/papers/41859044PubMed
41710664Case Report: Immunotherapy-induced myocarditis requiring pacemaker insertion in an older adult. what happens if we rechallenge?Front Oncol2026https://conductscience.org/library/papers/41710664PubMed
41680658Nomogram-based prediction of checkpoint inhibitor pneumonitis in lung cancer patients.BMC Cancer2026https://conductscience.org/library/papers/41680658PubMed
41647338Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data.ESMO Real World Data Digit Oncol2025https://conductscience.org/library/papers/41647338PubMed
40940933Immunotherapy-Associated Cardiotoxicity: Current Insights and Future Directions for Precision Cardio-Oncology.Cancers (Basel)2025https://conductscience.org/library/papers/40940933PubMed
40851558Hemoglobin is associated with cardiotoxicity in melanoma patients without anemia receiving immune checkpoint inhibitor therapy.Int J Cardiol Heart Vasc2025https://conductscience.org/library/papers/40851558PubMed
40821806The impact of immune checkpoint inhibition on atherosclerosis in cancer patients.Front Immunol2025https://conductscience.org/library/papers/40821806PubMed
40741581Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitors: Interpreting the Discrepancy Between Clinical Trials and Real-World Data.Cureus2025https://conductscience.org/library/papers/40741581PubMed
40704609Risk factors of immune checkpoint inhibitor-related cardiotoxicity: a scoping review.Oncologist2025https://conductscience.org/library/papers/40704609PubMed
40411721Unmasking the Rare but Lethal Cardiac Complications of Immune Checkpoint Inhibitor Therapy: A Review of Mechanisms, Risk Factors, and Management Strategies.Curr Treat Options Oncol2025https://conductscience.org/library/papers/40411721PubMed
39982537Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis.Cancer Metastasis Rev2025https://conductscience.org/library/papers/39982537PubMed
39981496Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor-Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer.Cancer Innov2025https://conductscience.org/library/papers/39981496PubMed
39949762Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.Front Immunol2025https://conductscience.org/library/papers/39949762PubMed
39738878The role of tumor types in immune-related adverse events.Clin Transl Oncol2025https://conductscience.org/library/papers/39738878PubMed
39286288Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment.Drug Des Devel Ther2024https://conductscience.org/library/papers/39286288PubMed
39082198Early identification of severe immune checkpoint inhibitor associated myocarditis: From an electrocardiographic perspective.Cancer Med2024https://conductscience.org/library/papers/39082198PubMed
38137806Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge.J Clin Med2023https://conductscience.org/library/papers/38137806PubMed
37955712High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy.Clin Res Cardiol2024https://conductscience.org/library/papers/37955712PubMed
37902905Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancer.Invest New Drugs2023https://conductscience.org/library/papers/37902905PubMed
37711551Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma-a review and prospects for the future.Front Cardiovasc Med2023https://conductscience.org/library/papers/37711551PubMed

See all 24 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35669482

GET https://conductscience.org/api/papers/v1/35669482/references?page=2